✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
If weight loss is inadequate (
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Anti-obesity medications may be considered in the subjects with BMI ≥30 kg/m2, or with BMI 27-29.9 kg/m2 and weight-related comorbidities, whom weight reduction is not achieved via lifestyle modifications alone.
📊
Key Findings & Data:Anti-obesity medications may be considered in the subjects with BMI ≥30 kg/m2, or with BMI 27-29.9 kg/m2 and weight-related comorbidities, whom weight reduction is not achieved via lifestyle modifications alone.
💡
Conclusion & Impact:If weight loss is inadequate (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Anti-obesity medications may be considered in the subjects with BMI ≥30 kg/m2, or with BMI 27-29.9 kg/m2 and weight-related comorbidities, whom weight reduction is not achieved via lifestyle modifications alone. If weight loss is inadequate (
🔖
Cite This Article
Sahin, I., Topaloglu, O. (2022). Pharmacological treatment of obesity in clinical practice. Medicine Science, Cilt: 10 - Sayı: 2, 651–657. https://ajindex.com/articles/579631